Devora Delman

4PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 08, 2025
Nonredundant Immune Checkpoints Direct Therapeutic Resistance to Chemoimmunotherapy in Pancreatic Ductal Adenocarcinoma.

Meredith L Stone, Veronica M Herrera, Yan Li

|May 02, 2024
Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.

Jonathan H Sussman, Nathalia Kim, Samantha B Kemp

|Aug 03, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.

Gregory L Beatty, Devora Delman, Jiayi Yu

|May 04, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.

Cécile Alanio, Zev A Binder, Renee B Chang

Pageof 1

Frequent Collaborators

4 joint publications

Gregory L Beatty

2 joint publications

Renee B Chang

2 joint publications

Joey H Li

1 joint publications

Cécile Alanio